WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2025 Issue has been successfully launched on 1 NOVEMBER 2025.

Abstract

BEYOND HRT: SIDDHARTHAKA TAILA AS RASAYANA FOR OSTEOARTHRITIS IN POSTMENOPAUSAL WOMEN

Dr. Sindhura A. S.* and Dr. Abdul Khader

ABSTRACT

Introduction: Menopause is a physiological process universally affects all women who reach midlife. Knee Osteoarthritis, the most common articular disorder begins asymptomatically after menopause in the 2nd and 3rd decades and is extremely common by age 70. OA is a chronic degenerative disorder of multifactorial etiology characterized by loss of articular cartilage and peri-articular bone remodelling. The manifestation of osteoarthritis after the decline of estrogen in menopause has a different pathology compared to the osteoarthritis that occur as a degenerative joint disease. A better understanding of the role that estrogen and its deficiency plays in the molecular mechanisms of menopause induced osteoarthritic changes that affect the different joint structures has helped development of new and precise therapeutic strategies to prevent and/or restore damaged articular tissues in OA. Siddharthaka taila is mentioned in Bhaishajya Rathnavali in Vata vyadhi adhikara. It is indicated in Sandhigata vata. Siddharthaka taila is enriched with phytoestrogen properties which is beneficial in post-menopausal women, especially of postmenopausal women with osteoarthritis. This clinical study aims at providing an insight towards usage of Siddharthaka taila as Rasayana alternate to HRT in Ayurveda in the management of Osteoarthritis in post-menopausal women. Aims and objectives: Clinical & biochemical evaluation of post-menopausal osteoarthritis patients before & after oral administration of Siddharthaka taila. Materials and methods: It is an observational clinical study with pre and post-test design. 10 female patients between the age group 40-70 years who have attained menopause, having the signs and symptoms of knee Osteoarthritis fulfilling the diagnostic criteria of JanuSandhigata Vata were taken into the study from the O.P.D and I.P.D of Sri Kalabyraveshwara Swamy Ayurveda Medical College Hospital and Research Centre, Bangalore. All patients were administered with oral administration of Siddharthaka taila. Clinical & biochemical evaluation were repeated 30 days after the last dose of oral administration of Siddharthaka taila. Result: Result obtained were statistically analysed by using paired t test. Post test assessment showed statistically highly significant results in reduction in WOMAC score and statistically significant results in improvement in serum estradiol estimation. Conclusion: It can be concluded that Siddharthaka Taila as a therapeutic intervention has beneficial effect on the patients of post-menopausal Osteoarthritis & should be included as a routine treatment along with conventional line of management in Osteoarthritis.

Keywords: .


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More